NTLA
Intellia Therapeutics, Inc. · Healthcare
EVP, Dev, Corp Strategy Andrew Schiermeier bought $118K of Intellia Therapeutics, Inc.
Bought$117,875
$15.72Price
7,500Shares
+87%Stake
What NTLA did for a copier
Prices for NTLA after this filing aren't in yet.
Andrew Schiermeier's record
No other buys on record. A record shows here once 3 buys have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Mar 6. Filed Tue, Mar 12, 12:38 PM ET, during the session. Not investment advice.